Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Wealth mindset tips for new business owners can transform your approach to finance. Embrace a positive mindset to enhance your business success.
25,283 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Intel stock has moved faster than its turnaround plan in many eyes. As Lip-Bu Tan reshapes the company, investors mus...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
Tally, a leading DAO governance tool used by hundreds of communities, will shut down after five years as regulators c...
Sharplink's 2026 earnings path hinges on user growth, margins, and regulatory resilience. This guide breaks down the ...
Duke University researchers unveiled Argus, a 20-legged robot capable of moving in any direction. The breakthrough co...
When prices swing, crypto investors look for signals. This article breaks down what ethereum falling below $1,600 cou...
Lennar's latest results reveal a pricing move not seen in years. This article breaks down why lennar hasn't sold home...
An appeals court clears the Trump administration to reinstall interpretive panels at George Washington's Philadelphia...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
A multi-front conflict in the Middle East escalates, drawing in regional powers and global markets. Energy supplies, ...